Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ketamine in Centrally Sensitized Endometriosis Patients
NCT07182032Phase 4Withdrawn
- Sponsor
- University Hospitals Cleveland Medical Center
- Start
- Feb 2026
- Primary completion
- Jun 2028
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of ketamine in postoperative pain, Central sensitization (CS), sponsored by University Hospitals Cleveland Medical Center. Planned start Feb 2026; status: withdrawn.
02
Drugs
ketamine
03
Conditions
postoperative painCentral sensitization (CS)
Beyond the preview
Go deeper on NCT07182032.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07182032.